Spago Nanomedical Financials
| SPAGO Stock | SEK 0.21 0.01 5.00% |
Spago |
Please note, the imprecision that can be found in Spago Nanomedical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Spago Nanomedical AB. Check Spago Nanomedical's Beneish M Score to see the likelihood of Spago Nanomedical's management manipulating its earnings.
Spago Nanomedical Stock Summary
Spago Nanomedical competes with Alligator Bioscience, Abliva AB, Ascelia Pharma, and Saniona AB. Spago Nanomedical AB develops nanomaterials for cancer diagnostics and treatment. Spago Nanomedical AB was founded in 2007 and is based in Lund, Sweden. Spago Nanomedical is traded on Stockholm Stock Exchange in Sweden.| Instrument | Sweden Stock View All |
| Exchange | Stockholm Exchange |
| ISIN | SE0004899474 |
| Business Address | Scheelevgen 22, Lund, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | spagonanomedical.se |
| Phone | 46 4 68 11 88 |
| Currency | SEK - Swedish Kronor |
You should never invest in Spago Nanomedical without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Spago Stock, because this is throwing your money away. Analyzing the key information contained in Spago Nanomedical's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Spago Nanomedical Key Financial Ratios
There are many critical financial ratios that Spago Nanomedical's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Spago Nanomedical reports annually and quarterly.Spago Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Spago Nanomedical's current stock value. Our valuation model uses many indicators to compare Spago Nanomedical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Spago Nanomedical competition to find correlations between indicators driving Spago Nanomedical's intrinsic value. More Info.Spago Nanomedical AB is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Spago Nanomedical's earnings, one of the primary drivers of an investment's value.Spago Nanomedical Systematic Risk
Spago Nanomedical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Spago Nanomedical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Spago Nanomedical correlated with the market. If Beta is less than 0 Spago Nanomedical generally moves in the opposite direction as compared to the market. If Spago Nanomedical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Spago Nanomedical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Spago Nanomedical is generally in the same direction as the market. If Beta > 1 Spago Nanomedical moves generally in the same direction as, but more than the movement of the benchmark.
Spago Nanomedical Thematic Clasifications
Spago Nanomedical AB is part of Drugs investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery
This theme covers Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. Get More Thematic Ideas
| Drugs | View |
Spago Nanomedical January 23, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Spago Nanomedical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Spago Nanomedical AB. We use our internally-developed statistical techniques to arrive at the intrinsic value of Spago Nanomedical AB based on widely used predictive technical indicators. In general, we focus on analyzing Spago Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Spago Nanomedical's daily price indicators and compare them against related drivers.
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 19.09 | |||
| Value At Risk | (5.56) | |||
| Potential Upside | 5.88 |
Additional Tools for Spago Stock Analysis
When running Spago Nanomedical's price analysis, check to measure Spago Nanomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Spago Nanomedical is operating at the current time. Most of Spago Nanomedical's value examination focuses on studying past and present price action to predict the probability of Spago Nanomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Spago Nanomedical's price. Additionally, you may evaluate how the addition of Spago Nanomedical to your portfolios can decrease your overall portfolio volatility.